INTELLIA THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

10 Jan 2025 08:45:07 By NetDania Notify

Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement of its Late-Stage Programs, NTLA-2002 and Nexiguran Ziclumeran (nex-z)

09 Jan 2025 15:00:00 By Nasdaq GlobeNewswire

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 Jan 2025 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

31 Dec 2024 09:00:10 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

30 Dec 2024 08:52:39 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

26 Dec 2024 08:45:05 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

19 Dec 2024 08:59:11 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

18 Dec 2024 13:25:27 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

13 Dec 2024 09:50:31 By NetDania Notify

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 Dec 2024 15:01:00 By Nasdaq GlobeNewswire

Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy

25 Nov 2024 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

20 Nov 2024 08:51:21 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

18 Nov 2024 09:10:43 By NetDania Notify

Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis

16 Nov 2024 09:16:00 By Nasdaq GlobeNewswire

Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

07 Nov 2024 06:30:00 By Nasdaq GlobeNewswire

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

05 Nov 2024 15:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

31 Oct 2024 08:45:01 By NetDania Notify

Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024

31 Oct 2024 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

30 Oct 2024 08:45:22 By NetDania Notify

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

29 Oct 2024 10:48:28 By NetDania Notify